We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.89%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+40.89%
3 Year Est. Return
+115.82%
5 Year Est. Return
+132.07%
10 Year Est. Return
+517.81%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
+$4.43B
Cap. Flow %
4.04%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,445
Increased
2,647
Reduced
3,047
Closed
1,267
Avg Time Held Equity + Options
6.9 quarters
Top 10 Avg Time Held Equity + Options
5.6 quarters
Top 20 Avg Time Held Equity + Options
5 quarters
Avg Time Held Equity only
4.8 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.22%
2 Technology 7.41%
3 Consumer Discretionary 6.04%
4 Financials 5.89%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AX icon
3851
PUT
Axos Financial
AX
$4.98B
$985K ﹤0.01%
37,700
+28,700
+319% +$829K
2014 Q3
10 quarters
PCRX icon
3852
PUT
Pacira BioSciences
PCRX
$1.02B
$985K ﹤0.01%
21,600
-3,200
-13% -$138K
2014 Q2
11 quarters
SCHE icon
3853
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$985K ﹤0.01%
+41,085
New +$957K
2017 Q1
0 quarters
SHOR
3854
DELISTED
ShoreTel, Inc.
SHOR
$985K ﹤0.01%
160,153
+41,770
+35% +$280K
2016 Q3
2 quarters
AEO icon
3855
CALL
American Eagle Outfitters
AEO
$2.94B
$984K ﹤0.01%
70,100
-6,400
-8% -$95.1K
2013 Q2
15 quarters
TNC icon
3856
Tennant Co
TNC
$1.12B
$984K ﹤0.01%
+13,540
New +$954K
2017 Q1
0 quarters
CSOD
3857
CALL
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$984K ﹤0.01%
25,300
-47,700
-65% -$1.97M
2013 Q4
13 quarters
OKS
3858
PUT
DELISTED
Oneok Partners LP
OKS
$983K ﹤0.01%
18,200
+8,000
+78% +$400K
2013 Q2
15 quarters
KANG
3859
DELISTED
iKang Healthcare Group, Inc.
KANG
$982K ﹤0.01%
67,288
-100,015
-60% -$1.64M
2016 Q3
2 quarters
UCO icon
3860
PUT
ProShares Ultra Bloomberg Crude Oil
UCO
$400M
$981K ﹤0.01%
8,256
-5,376
-39% -$697K
2016 Q3
2 quarters
SBGI icon
3861
PUT
Sinclair Inc
SBGI
$923M
$980K ﹤0.01%
24,200
-14,100
-37% -$519K
2013 Q2
15 quarters
WBIF icon
3862
WBI BullBear Value 3000 ETF
WBIF
$22.4M
$979K ﹤0.01%
38,315
-1,948
-5% -$49.1K
2016 Q2
3 quarters
A icon
3863
PUT
Agilent Technologies
A
$48B
$978K ﹤0.01%
18,500
-14,000
-43% -$707K
2013 Q2
15 quarters
EXLS icon
3864
EXL Service
EXLS
$5.39B
$978K ﹤0.01%
+103,295
New +$969K
2017 Q1
0 quarters
FXF icon
3865
Invesco CurrencyShares Swiss Franc Trust
FXF
$375M
$977K ﹤0.01%
10,281
+473
+5% +$44.9K
2014 Q3
10 quarters
ABMD
3866
PUT
DELISTED
Abiomed Inc
ABMD
$977K ﹤0.01%
7,800
+1,000
+15% +$116K
2014 Q4
9 quarters
ITB icon
3867
iShares US Home Construction ETF
ITB
$2.27B
$976K ﹤0.01%
30,515
-24,217
-44% -$725K
2016 Q4
1 quarter
CCO icon
3868
Clear Channel Outdoor Holdings
CCO
$1.22B
$975K ﹤0.01%
161,154
-2,715
-2% -$14.3K
2015 Q4
5 quarters
GAL icon
3869
State Street Global Allocation ETF
GAL
$317M
$975K ﹤0.01%
28,228
+2,773
+11% +$94.4K
2016 Q4
1 quarter
FE icon
3870
PUT
FirstEnergy
FE
$25.8B
$974K ﹤0.01%
30,600
-53,600
-64% -$1.65M
2013 Q2
15 quarters
MSCI icon
3871
MSCI
MSCI
$40.2B
$974K ﹤0.01%
+10,018
New +$908K
2017 Q1
0 quarters
CSRA
3872
DELISTED
CSRA Inc.
CSRA
$974K ﹤0.01%
33,244
-223,238
-87% -$6.85M
2015 Q4
5 quarters
PHG icon
3873
PUT
Philips
PHG
$23.6B
$973K ﹤0.01%
+40,922
New +$918K
2017 Q1
0 quarters
SCCO icon
3874
CALL
Southern Copper
SCCO
$168B
$973K ﹤0.01%
29,584
-50,434
-63% -$1.69M
2013 Q2
15 quarters
CDR
3875
DELISTED
Cedar Realty Trust, Inc
CDR
$972K ﹤0.01%
29,349
+25,095
+590% +$963K
2016 Q3
2 quarters

Similar funds

Citadel Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.

  • Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.